The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index; 42 of the 69 sources its claims cite were checked for support.
The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion
Open accessAbstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) and its advanced inflammatory subtype, metabolic dysfunction-associated steatohepatitis (MASH), are becoming increasingly prevalent liver disorders driven by complex interactions between metabolic stress, immune dysregulation, and fibrotic remodeling. Regulatory T cells (Tregs), traditionally recognized for their immunosuppressive functions, have emerged as key modulators of hepatic inflammation, fibrosis, and systemic metabolic balance. While Tregs can suppress pro-inflammatory immune responses and mitigate liver injury, accumulating evidence highlights their paradoxical roles in liver fibrosis, including the promotion of hepatic stellate cell activation and profibrotic remodeling. This review critically examines the dual and context-dependent roles of Tregs in MASLD and MASH, emphasizing implications for therapeutic intervention. Additionally, we discuss current preclinical strategies aimed at modulating Treg abundance and function, highlighting the challenges and opportunities associated with developing stage-specific therapeutic approaches that consider not only local hepatic effects but also potential systemic metabolic consequences.
Overview
CoChat Summary
## TL;DR
This is a narrative review of how regulatory T cells (Tregs) can both protect against inflammation and also promote fibrosis in MASLD/MASH. The paper argues that Treg-targeted therapy will likely need to be stage-specific because boosting Tregs may help early disease but worsen fibrosis or tumor-promoting contexts later.
## Key findings
- Tregs are presented as immunosuppressive cells that can limit hepatic inflammation in MASLD/MASH; Treg depletion worsened hepatic inflammation in MASLD, and restoring the Th17/Treg balance is proposed as a therapeutic direction.
- The paper emphasizes a paradoxical fibrotic role: Tregs can promote hepatic stellate cell (HSC) activation through TGF-β-dependent signaling and IL-8 induction, and a subset of Tregs producing amphiregulin (AREG) drives profibrotic programs.
- In one cited diet-induced MASH study, Treg-specific deletion of Areg attenuated fibrosis in multiple models without significantly changing hepatic lipid accumulation or inflammation; mice lacking Egfr specifically on HSCs were protected from both fibrosis and glucose dysregulation.
- The review notes that at least one model linked the ATF4–integrin αvβ8 axis in hepatic Tregs to fibrosis; blockade of integrin αvβ8 reduced active TGF-β and attenuated fibrosis in mice.
## Methods
- Not stated in the paper.
- The article is a review that synthesizes prior murine and human studies on Treg biology in MASLD/MASH, rather than presenting a new experimental cohort or trial.
- Its main analysis is a narrative, mechanism-focused interpretation of published findings on Treg phenotypes, immunometabolic regulation, and therapeutic strategies.
## Limitations
- The paper states that the roles of Tregs in MASLD and MASH “remain unclear,” and that no distinct liver-specific Treg phenotype has been conclusively identified.
- It also states that direct experimental evidence for some proposed mechanisms is limited, including the FOXO–Treg axis in MASLD.
- Evident from the text: this is a review of preclinical and prior human studies, so its conclusions depend on heterogeneous external studies rather than new primary data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
36 Valid · 1 Not valid · 10 Not checked · 17 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although simple steatosis is often clinically silent, progression to MASH reflects a key transition mediated by lipotoxic injury, sterile and metabolic inflammation, and progressive fibrotic remodeling (Meyer et al. 2024).”
§ The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion > Pathologic overview of MASLD and MASH
What the sources say
- Supportedcites Meyer et al. 2024 source
The Introduction describes the transition from simple steatosis to liver inflammation and identifies inflammation as a driver of fibrosis. The Abstract links innate-immune activation to excess lipids and lipotoxicity, while the Conclusions describe MASH as involving sterile inflammation within a metabolic-inflammatory disease. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The degree of liver fibrosis remains the most robust histological predictor of liver-related morbidity and mortality in patients with MASLD (Dulai et al. 2017).”
§ The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion > Pathologic overview of MASLD and MASH
What the sources say
- Partly supportedcites Dulai et al. 2017 sourceExperimental — accuracy not yet measured
The Introduction calls fibrosis progression among the most important predictors of disease outcomes in NAFLD, and the Discussion (Main findings) reports that liver-related mortality rises with fibrosis stage. The meta-analysis does not assess liver-related morbidity or directly compare fibrosis with other histological predictors, so it does not establish the full claim that fibrosis is the most robust predictor of both outcomes. Page numbers are not available in our copy. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“growing evidence has highlighted the critical contribution of immune dysregulation to its pathogenesis.”
§ The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion > Introduction
What the sources say
- Supportedcites Shrestha et al. 2025 source
The section ‘Roles of Immune Cells in MASLD and MASH Pathogenesis’ states that immune responses play a critical role in MASLD development and progression. It also describes how disrupted immune balance and interactions among immune cells drive liver inflammation and fibrosis, supporting the paraphrase about immune dysregulation. (LLM, conf=0.92)
- Supportedcites Sutti and Albano 2020 source
The 'Innate immunity in NASH' section describes pro-inflammatory immune mechanisms that contribute to the evolution of NAFLD and reports that blocking inflammatory signalling ameliorated experimental NASH. The 'Oxidative stress and NASH immunity' section also links adaptive immune responses to hepatic inflammation and injury. Together, these passages support the broad claim that immune dysregulation contributes to disease progression. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“These cells exert immunosuppressive effects through multiple mechanisms, including cytokine secretion, metabolic disruption of effector T cells, and modulation of antigen-presenting cells (APCs) (Bilate and Lafaille 2012; Josefowicz et al. 2012; Wing et al. 2019).”
§ The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion > Introduction
What the sources say
- Not checked — no full text of the sourcecites Bilate and Lafaille 2012 source
- Supportedcites Josefowicz et al. 2012 source
The “Molecular Mechanisms of Treg Cell–Mediated Suppression” section describes Treg secretion of immunosuppressive cytokines, deprivation of effector T cells’ IL-2 and inhibition through adenosine signaling, and effects on dendritic cells as antigen-presenting cells. Together, these support the three mechanisms in the citing sentence. Page numbers were not supplied in the passages. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites Wing et al. 2019 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Tregs consistently exhibit an increased susceptibility to apoptosis in MASH (Sutti and Albano 2020).”
§ The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion > Tregs in the microenvironment of MASLD and MASH
What the sources say
- Partly supportedcites Sutti and Albano 2020 sourceExperimental — accuracy not yet measured
The “Regulatory T cells in the liver” section says Treg cells in fatty livers are more susceptible to apoptosis in response to oxidative stress than those in nonfatty livers. It does not establish that this occurs consistently in MASH specifically, or without the oxidative-stress condition. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
19 more claims · 8 with their cited sources checked
Create a free account to see all 64 claims and to verify the 2 references still open.
- Probably not a substantial claim. 2
- It may state two separate claims as one. 39
Citations
Cites
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608 · cited 1×
“CD25, initially used to identify suppressive CD4 + T cells, is constitutively expressed by most endogenous CD4 + Tregs (Sakaguchi et al. 1995).”
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549 · cited 1×
“…characteristics, and suppressive function are modulated by a range of local factors, including the cytokine milieu, lipid-derived metabolites, bile acids, and gut microbiota-associated molecules, many of which are altered in MASLD (Furusawa et al. 2013; Song et al. 2020; Zhou et al. 2022).”
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“…functions, is also a potent pro-fibrotic cytokine in liver disease; under conditions of sustained hepatic injury, TGF-β promotes HSC activation and their transdifferentiation into ECM-producing myofibroblasts, thus driving fibrogenic progression (Dewidar et al. 2019; Tsuchida and Friedman 2017).”
Regulatory T cells: mechanisms of differentiation and function
Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866 · cited 1×
“These cells exert immunosuppressive effects through multiple mechanisms, including cytokine secretion, metabolic disruption of effector T cells, and modulation of antigen-presenting cells (APCs) (Bilate and Lafaille 2012; Josefowicz et al. 2012; Wing et al. 2019).”
Non-alcoholic fatty liver disease
Powell, E. E., Wong, V. W.-S., & Rinella, M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32511-3 · Cited by 2,789
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669 · cited 2×
“Most thymic Treg cells belong to the CD4 + lineage, comprising approximately 5% of mature CD4 + single-positive thymocytes (Sakaguchi 2005).”
The integrated stress response
Pakos‐Zebrucka, K., Koryga, I., Mnich, K., Ljujic, M., Samali, A., & Gorman, A. M. (2016) · The EMBO Reports · doi:10.15252/embr.201642195 · Cited by 2,659
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470 · cited 2×
“(E) By expressing CD39 and CD73, Tregs convert extracellular ATP to adenosine, which binds to adenosine receptors on Teff cells and suppresses their activation (Deaglio et al. 2007; Ohta and Sitkovsky 2014).”
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145 · cited 1×
“However, under conditions of obesity, these adipose Tregs are reduced in number and lose their suppressive capacity, which exacerbates adipose tissue inflammation and indirectly promotes hepatic steatosis and liver injury(Feuerer et al. 2009; Kawai et al. 2021).”
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · cited 1×
“MASH is characterized by hepatocyte injury, lobular inflammation, and progressive fibrosis (Loomba et al. 2021).”
Cited by
Cathepsin A deficiency exacerbates LPS-induced inflammatory liver injury and apoptosis
Chae, H. Y., Park, J. Y., Hyung, H., Ko, J., Lim, S., Lee, Y. J., Kim, M. O., Park, S., Choi, D. K., Jang, S., et al. (2026) · Animal Cells and Systems · doi:10.1080/19768354.2026.2671489 · Cited by 1
“Previous studies have shown that a Th17/Treg imbalance is strongly associated with autoimmunity and chronic inflammation (Miossec and Kolls 2012; Lee 2018; Lee et al. 2026).”
Self-citation
Metadata
- Authors
- Lee, S. E., Jo, M. G., Park, S. W., Kim, H. J., Yun, S. P., & Kim, J.-W.
- Affiliations
- Gyeongsang National University (KR)
- Gyeongsang National University
- Corresponding author
- Yun, Seung Pil
- Kim, Jong-Won
- Venue
- Animal Cells and Systems
- Publisher
- Informa UK Limited
- Published
- 2026-02-16
- Volume
- 30
- Issue
- 1
- Pages
- 250-264
- ISSN
- 1976-8354 (ISSN-L)
- 2151-2485
- PMC
- PMC12912241
- OpenAlex
- W7128990397
- Semantic Scholar
- fbf6c4d174ebc8f730f8b7c23b362252347d4346
- Cited by
- 2
- References
- 121
- Citations by year
- 2026: 2
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Animal Cells and Systems (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (RS-2023-00219399)
- Ministry of Science and ICT (MSIT), Republic of Korea
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- regulatory T cells, nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, liver fibrosis, liver inflammation, hepatic stellate cell activation, immune dysregulation, metabolic stress, liver injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion. https://app.cochat.ai/papers/10.1080/19768354.2026.2630463
- The paper
- Lee, S. E., Jo, M. G., Park, S. W., Kim, H. J., Yun, S. P., & Kim, J.-W. (2026). The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion. Animal Cells and Systems. https://doi.org/10.1080/19768354.2026.2630463
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.